Skip to content

MoonLake Immunotherapeutics MLTX United Kingdom — Long-Lived Assets

Other geography segments

Portugal
$948K-22.5%
Switzerland
$888K+64.7%

Similar metrics at other companies

Korn Ferry logo
KFYUnited Kingdom — Long-Lived Assets
$71.63M+11.4%
Tetra Tech logo
TTEKUnited Kingdom — Long-Lived Assets
$20.76M+6.4%
Oceaneering International logo
OIIUnited Kingdom — Long-Lived Assets
$85.39M+10.1%
Workiva logo
WKUnited Kingdom — Long-Lived Assets
$4.8M
nCino, Inc. logo
NCNOUnited Kingdom — Long-Lived Assets
$15.96M+17.8%
GXO Logistics logo
GXOUnited Kingdom — Long-Lived Assets
$1.19B+18.3%

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.56B-45.9%
Enterprise value$1.36B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's united kingdom — long-lived assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's united kingdom — long-lived assets?
MoonLake Immunotherapeutics (MLTX) reported united kingdom — long-lived assets of $553K in Q1 2026.
How has MoonLake Immunotherapeutics's united kingdom — long-lived assets changed year-over-year?
MoonLake Immunotherapeutics's united kingdom — long-lived assets decreased by 64.0% year-over-year, from $1.54M to $553K.
What does united kingdom — long-lived assets mean?
This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the United Kingdom. It reflects the company's investment in regional infrastructure, research facilities, or intellectual property holdings specific to this geographic market. Monitoring this value helps investors assess the company's operational footprint and capital allocation strategy within the UK regulatory and economic environment.